Literature DB >> 21896610

Evidence of comparative efficacy should have a formal role in European drug approvals.

Corinna Sorenson1, Huseyin Naci, Jonathan Cylus, Elias Mossialos.   

Abstract

Mesh：

Year:  2011        PMID： 21896610     DOI： 10.1136/bmj.d4849

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  17 in total

1.  Optimizing investigator-led oncology research in Europe.

Authors:  Tiziano Barbui; Magnus Björkholm; Alois Gratwohl
Journal:  Haematologica       Date:  2012-06       Impact factor: 9.941

2.  New drugs: evidence relating to their therapeutic value after introduction to the market.

Authors:  Mariam Ujeyl; Claudia Schlegel; Siegbert Walter; Ursula Gundert-Remy
Journal:  Dtsch Arztebl Int       Date:  2012-02-17       Impact factor: 5.594

3.  Comparison of Drug Utilization Patterns in Observational Data: Antiepileptic Drugs in Pediatric Patients.

Authors:  Florence T Bourgeois; Karen L Olson; Annapurna Poduri; Kenneth D Mandl
Journal:  Paediatr Drugs       Date:  2015-10       Impact factor: 3.022

4.  Efficacy of Jian'ganle () versus Hugan Pian (), glucuronolactone and reduced glutathione in prevention of antituberculosis drug-induced liver injury.

Authors:  Quan Zhang; Fang-Ying Zhong; Meng Wu; Xin-Ping Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-06-18

5.  EMA and FDA psychiatric drug trial guidelines: assessment of guideline development and trial design recommendations.

Authors:  Kim Boesen; Peter C Gøtzsche; John P A Ioannidis
Journal:  Epidemiol Psychiatr Sci       Date:  2021-04-30       Impact factor: 6.892

6.  Comparative effectiveness research: an empirical study of trials registered in ClinicalTrials.gov.

Authors:  Florence T Bourgeois; Srinivas Murthy; Kenneth D Mandl
Journal:  PLoS One       Date:  2012-01-09       Impact factor: 3.240

Review 7.  Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study.

Authors:  Huseyin Naci; John P A Ioannidis
Journal:  BMJ       Date:  2013-10-01

8.  The effects of industry sponsorship on comparator selection in trial registrations for neuropsychiatric conditions in children.

Authors:  Adam G Dunn; Kenneth D Mandl; Enrico Coiera; Florence T Bourgeois
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

Review 9.  Treatment comparison in rheumatoid arthritis: head-to-head trials and innovative study designs.

Authors:  Ennio Giulio Favalli; Serena Bugatti; Martina Biggioggero; Roberto Caporali
Journal:  Biomed Res Int       Date:  2014-04-16       Impact factor: 3.411

10.  Strength of clinical evidence leading to approval of novel cancer medicines in Europe: A systematic review and data synthesis.

Authors:  Alberto Farina; Federico Moro; Frederick Fasslrinner; Annahita Sedghi; Miluska Bromley; Timo Siepmann
Journal:  Pharmacol Res Perspect       Date:  2021-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.